β cell ER stress and the implications for immunogenicity in type 1 diabetes

Type 1 diabetes (T1D) is a chronic autoimmune disease characterized by hyperglycemia due to progressive immune-mediated destruction of insulin-producing pancreatic islet β cells. Although many elegant studies have identified β cell autoantigens that are targeted by the autoimmune response, the mecha...

Full description

Bibliographic Details
Main Authors: Meghan L. Marre, Eddie A. James, Jon D. Piganelli
Format: Article
Language:English
Published: Frontiers Media S.A. 2015-10-01
Series:Frontiers in Cell and Developmental Biology
Subjects:
Online Access:http://journal.frontiersin.org/Journal/10.3389/fcell.2015.00067/full
id doaj-f754a0743bb9447b85a724f74c01f07e
record_format Article
spelling doaj-f754a0743bb9447b85a724f74c01f07e2020-11-24T22:55:12ZengFrontiers Media S.A.Frontiers in Cell and Developmental Biology2296-634X2015-10-01310.3389/fcell.2015.00067160323β cell ER stress and the implications for immunogenicity in type 1 diabetesMeghan L. Marre0Eddie A. James1Jon D. Piganelli2University of PittsburghBenaroya Research Institute at Virginia MasonUniversity of PittsburghType 1 diabetes (T1D) is a chronic autoimmune disease characterized by hyperglycemia due to progressive immune-mediated destruction of insulin-producing pancreatic islet β cells. Although many elegant studies have identified β cell autoantigens that are targeted by the autoimmune response, the mechanisms by which these autoantigens are generated remain poorly understood. Normal β cell physiology includes a high demand for insulin production and secretion in response to dynamic glucose sensing. This secretory function predisposes β cells to significantly higher levels of endoplasmic reticulum (ER) stress compared to nonsecretory cells. In addition, many environmental triggers associated with T1D onset further augment this inherent ER stress in β cells. ER stress may increase abnormal post-translational modification (PTM) of endogenous β cell proteins. Indeed, in other autoimmune disorders such as celiac disease, systemic lupus erythematosus, multiple sclerosis, and rheumatoid arthritis, abnormally modified neo-antigens are presented by antigen presenting cells in draining lymph nodes. In the context of genetic susceptibility to autoimmunity, presentation of neo-antigens activates auto-reactive T cells and pathology ensues. Therefore, the ER stress induced by normal β cell secretory physiology and environmental triggers may be sufficient to generate neo-antigens for the autoimmune response in T1D. This review summarizes what is currently known about ER stress and protein PTM in target organs of other autoimmune disease models, as well as the data supporting a role for ER stress-induced neo-antigen formation in β cells in T1D.http://journal.frontiersin.org/Journal/10.3389/fcell.2015.00067/fulltype 1 diabetesAutoimmunity.er stresspost-translational modificationβ cellneo-antigen
collection DOAJ
language English
format Article
sources DOAJ
author Meghan L. Marre
Eddie A. James
Jon D. Piganelli
spellingShingle Meghan L. Marre
Eddie A. James
Jon D. Piganelli
β cell ER stress and the implications for immunogenicity in type 1 diabetes
Frontiers in Cell and Developmental Biology
type 1 diabetes
Autoimmunity.
er stress
post-translational modification
β cell
neo-antigen
author_facet Meghan L. Marre
Eddie A. James
Jon D. Piganelli
author_sort Meghan L. Marre
title β cell ER stress and the implications for immunogenicity in type 1 diabetes
title_short β cell ER stress and the implications for immunogenicity in type 1 diabetes
title_full β cell ER stress and the implications for immunogenicity in type 1 diabetes
title_fullStr β cell ER stress and the implications for immunogenicity in type 1 diabetes
title_full_unstemmed β cell ER stress and the implications for immunogenicity in type 1 diabetes
title_sort β cell er stress and the implications for immunogenicity in type 1 diabetes
publisher Frontiers Media S.A.
series Frontiers in Cell and Developmental Biology
issn 2296-634X
publishDate 2015-10-01
description Type 1 diabetes (T1D) is a chronic autoimmune disease characterized by hyperglycemia due to progressive immune-mediated destruction of insulin-producing pancreatic islet β cells. Although many elegant studies have identified β cell autoantigens that are targeted by the autoimmune response, the mechanisms by which these autoantigens are generated remain poorly understood. Normal β cell physiology includes a high demand for insulin production and secretion in response to dynamic glucose sensing. This secretory function predisposes β cells to significantly higher levels of endoplasmic reticulum (ER) stress compared to nonsecretory cells. In addition, many environmental triggers associated with T1D onset further augment this inherent ER stress in β cells. ER stress may increase abnormal post-translational modification (PTM) of endogenous β cell proteins. Indeed, in other autoimmune disorders such as celiac disease, systemic lupus erythematosus, multiple sclerosis, and rheumatoid arthritis, abnormally modified neo-antigens are presented by antigen presenting cells in draining lymph nodes. In the context of genetic susceptibility to autoimmunity, presentation of neo-antigens activates auto-reactive T cells and pathology ensues. Therefore, the ER stress induced by normal β cell secretory physiology and environmental triggers may be sufficient to generate neo-antigens for the autoimmune response in T1D. This review summarizes what is currently known about ER stress and protein PTM in target organs of other autoimmune disease models, as well as the data supporting a role for ER stress-induced neo-antigen formation in β cells in T1D.
topic type 1 diabetes
Autoimmunity.
er stress
post-translational modification
β cell
neo-antigen
url http://journal.frontiersin.org/Journal/10.3389/fcell.2015.00067/full
work_keys_str_mv AT meghanlmarre bcellerstressandtheimplicationsforimmunogenicityintype1diabetes
AT eddieajames bcellerstressandtheimplicationsforimmunogenicityintype1diabetes
AT jondpiganelli bcellerstressandtheimplicationsforimmunogenicityintype1diabetes
_version_ 1725657540183719936